Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
In weeks 14 every cell is filled (seven 10-unit doses)
This is a transitional step ahead of the broader BALANCE model rollout in January 2027, which may expand coverage further
You've found a medication that finally works, but then you see the price without insurance
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications primarily licensed for the treatment of type 2 diabetes mellitus and, in specific formulations, for weight management
After its promising effects on biomarkers in a phase 2 trial on AD [155], a phase 2a study in patients with mild-to-moderate dementia with Lewy bodies (DLB) showed a favourable safety profile as well as reversal of pathology in a BFCN degeneration mouse model [154]
Journal of Clinical Endocrinology & Metabolism, 91(3), 799805
US$ 21.98
US$ 26.04
US$ 28.16
US$ 25.79
US$ 26.53
